Contagious Mononucleosis – A Patient‑Friendly Guide

Overview

Mononucleosis, often called “mono” or the “kissing disease,” is an acute viral infection most commonly caused by the Epstein‑Barr virus (EBV). It is called “contagious” because it spreads easily through saliva, but it can also be transmitted via blood, semen, and organ transplantation. The disease is characterized by a prolonged fever, fatigue, and inflammation of the lymphatic system.

Who gets it? Mono primarily affects adolescents and young adults (ages 15‑30), though anyone can be infected. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 90 % of adults worldwide have been infected with EBV by age 40, but only 30‑50 % develop symptomatic mono.

Prevalence – In the United States, about 1 in 400 people are diagnosed with infectious mononucleosis each year, with a peak incidence in college campuses and other settings where close personal contact is common. Worldwide, available data suggest an annual incidence of 0.5–1.5 cases per 1,000 population.

Symptoms

Symptoms typically appear 4–6 weeks after exposure and last from a few weeks to several months. The classic triad is fever, sore throat, and lymphadenopathy, but many other signs may be present.

Common Symptoms

• Fever: Often 38‑40 °C (100.4‑104 °F) and may be intermittent.
• Sore throat: Red, inflamed tonsils; sometimes covered with a whitish exudate.
• Swollen lymph nodes: Most noticeable in the neck, but can involve the armpits and groin.
• Fatigue: Profound tiredness that can persist for weeks; many patients describe it as “crushing.”
• Headache and muscle aches (myalgia).

Other Frequently Reported Signs

• Loss of appetite
• Swollen spleen (splenomegaly) – felt as fullness or pain in the left upper abdomen
• Swollen liver (hepatomegaly) – usually mild and asymptomatic
• Rash – especially after taking certain antibiotics (e.g., ampicillin)
• Jaundice (rare)
• Night sweats
• Weight loss (usually mild)

When Symptoms Appear Unusual

If a patient develops severe abdominal pain, persistent vomiting, jaundice, or neurological changes (e.g., facial weakness, seizures, severe headache), these may signal complications and warrant urgent evaluation.

Causes and Risk Factors

Primary Cause

The overwhelming majority of contagious mononucleosis cases are caused by Epstein‑Barr virus (EBV), a member of the herpesvirus family. After primary infection, EBV remains dormant in B‑lymphocytes for life and may reactivate without causing symptoms.

Other Viral Triggers (Less Common)

• Human herpesvirus‑6 (HHV‑6)
• Cytomegalovirus (CMV) – called “CMV mononucleosis”
• HIV seroconversion

Risk Factors

• Age: 15‑30 years has the highest incidence.
• Close contact with saliva: Kissing, sharing drinks, utensils, or cigarettes.
• Living in crowded settings: Colleges, military barracks, boarding schools.
• Weakened immune system: HIV infection, organ transplant recipients, or patients on immunosuppressive drugs.
• Previous EBV infection: Re‑activation can cause mild mono‑like illness, especially in immunocompromised hosts.

Diagnosis

Because the early symptoms overlap with streptococcal pharyngitis and other viral infections, a careful clinical assessment is needed.

Clinical Evaluation

• History of exposure, symptom timeline, and risk factors.
• Physical examination focusing on tonsillar exudate, cervical lymphadenopathy, spleen size, and liver edge.

Laboratory Tests

1. Complete Blood Count (CBC): Typically shows lymphocytosis with >10 % atypical (reactive) lymphocytes.
2. Heterophile Antibody Test (Monospot): Rapid bedside test detecting heterophile antibodies; positive in 70‑90 % of adolescents but less sensitive in children <10 years.
3. EBV‑Specific Serology:
   • VCA‑IgM (viral capsid antigen IgM) – rises early, indicates acute infection.
   • VCA‑IgG – persists for life.
   • EBNA (EBV nuclear antigen) – appears 2‑3 months after infection; negative in acute phase.
4. Liver Function Tests (LFTs): Mild elevation of ALT/AST is common.
5. Throat culture or rapid strep test: Performed to rule out bacterial pharyngitis before prescribing antibiotics.

Imaging (When Indicated)

• Ultrasound or CT scan: Used if splenomegaly is suspected to assess size and rule out rupture.
• Chest X‑ray: Rarely needed, only if respiratory complications are suspected.

Treatment Options

There is no cure for EBV; management focuses on symptom relief and preventing complications.

Supportive Care (First‑Line)

• Rest: Adequate sleep and limitation of physical activity, especially contact sports, for at least 3–4 weeks.
• Hydration: Encourage water, herbal teas, and broths.
• Analgesics/Antipyretics: Acetaminophen or ibuprofen for fever and sore throat. Avoid aspirin in children <19 years due to Reye’s syndrome risk.
• Throat care: Salt‑water gargles, lozenges, and honey (if age‑appropriate).

Medications

• Corticosteroids: Reserved for severe airway obstruction, massive tonsillar hypertrophy, or severe hemolytic anemia. Typical regimen: Prednisone 0.5‑1 mg/kg/day for 5‑7 days.
• Antivirals: Agents such as acyclovir, valacyclovir, or ganciclovir have limited benefit in uncomplicated mono; they may be considered in immunocompromised patients.
• Antibiotics: Not indicated for EBV itself. If a secondary bacterial infection (e.g., streptococcal pharyngitis) is confirmed, appropriate antibiotics are prescribed. Avoid ampicillin/amoxicillin unless a bacterial infection is proven, as it frequently triggers a rash.

Lifestyle Modifications

• Refrain from contact sports (e.g., football, rugby, boxing) while splenomegaly is present. The risk of splenic rupture is highest in the first 3 weeks.
• Maintain a balanced diet rich in fruits, vegetables, lean protein, and whole grains to support immune recovery.
• Limit alcohol and caffeine, which may irritate a sore throat and worsen dehydration.

Living with Contagious Mononucleosis

Daily Management Tips

• Energy conservation: Use the “pacing” method – break tasks into short intervals with rest breaks.
• Hydration schedule: Aim for 2–3 L of fluid per day; set reminders if needed.
• Oral hygiene: Gentle brushing and alcohol‑free mouthwash reduce throat discomfort.
• Sleep hygiene: Keep a regular bedtime, dark cool bedroom, and limit screen time before sleep.
• Monitoring spleen size: Gentle palpation of the left upper abdomen (by a health professional) every 2–3 weeks until the spleen returns to normal.
• Return to school/work: Most patients feel well enough to resume light activities after 2–3 weeks; full activity should be cleared by a physician, especially before sport participation.

Emotional Well‑Being

Prolonged fatigue can affect mood. Encourage:

• Connecting with friends/family (virtual if needed).
• Light indoor exercise (e.g., walking) as tolerated.
• Seeking counseling or support groups for chronic‑illness coping.

Prevention

Because EBV is ubiquitous, complete prevention is impossible, but risk can be reduced.

Behavioral Strategies

• Avoid sharing drinking glasses, utensils, toothbrushes, or lip balm.
• Limit intimate kissing with individuals who have a recent sore throat or fever.
• Practice good hand hygiene—wash hands with soap for at least 20 seconds, especially after touching shared objects.

Environmental Measures

• Disinfect communal surfaces (doorknobs, phones) regularly with EPA‑approved cleaners.
• Use separate eating utensils in dormitories or shared housing.

Vaccination Outlook

Currently, no licensed vaccine exists for EBV, though several candidates are in Phase 2/3 clinical trials (e.g., gp350 subunit vaccine). Ongoing research aims to reduce primary infection rates and related cancers.

Complications

Most people recover uneventfully, but a minority develop complications that may require medical intervention.

Short‑Term Complications

• Splenic rupture: Though rare (<0.5 % of cases), it is life‑threatening and usually linked to trauma or vigorous activity.
• Airway obstruction: Massive tonsillar swelling can cause breathing difficulty; may need steroids or brief intubation.
• Hepatitis: Mild transaminase elevation in 10‑15 % of patients; severe hepatitis is uncommon.
• Hemolytic anemia or thrombocytopenia: Autoimmune phenomena in <1 % of cases.
• Neurologic involvement: Meningitis, encephalitis, or Guillain‑Barré syndrome (very rare).

Long‑Term Sequelae

• Chronic fatigue syndrome (post‑infective fatigue) – reported in up to 10 % of adolescents.
• Increased risk of certain cancers (e.g., Hodgkin lymphoma, nasopharyngeal carcinoma) linked to EBV latency, though absolute risk remains low.
• Re‑activation in immunocompromised patients can cause severe hepatitis, pneumonitis, or lymphoproliferative disease.

When to Seek Emergency Care

References

• Mayo Clinic. Infectious mononucleosis. Accessed June 2024.
• CDC. Epstein‑Barr virus (EBV) and infectious mononucleosis. Updated 2023.
• NIH National Institute of Allergy and Infectious Diseases. Epstein‑Barr Virus. 2022.
• Cleveland Clinic. Mononucleosis (Mono) Overview. 2023.
• World Health Organization. Epstein‑Barr virus fact sheet. 2022.
• Neumann, J. et al. “Long‑term outcomes after infectious mononucleosis.” Journal of Clinical Virology, 2021; 138: 104791.